{"id":{"repo_id":"mit","oai_identifier":"oai:dspace.mit.edu:1721.1/152712"},"canonical_url":"https://search.dev.ndltd.org/etd/mit/oai:dspace.mit.edu:1721.1/152712","repository":{"repo_id":"mit","name":"MIT","base_url":"https://dspace.mit.edu/oai/request"},"display":{"title":"The Consumer of Humans","abstract":"For decades, a dearth of scientific research, inadequate treatment and diagnostic tools have slowed progress in the fight to control tuberculosis globally. Scientists have developed important drugs, such as isoniazid, rifampin, and pyrazinamide, against the disease. But these drugs must be taken for several months, are sometimes ineffective, and can cause debilitating side effects. What’s more, if people don’t finish their treatments, it can lead to multidrug-resistant tuberculosis (MDR-TB), a form of the disease that is resistant to two of the four common drugs against TB, or, even more worryingly, extensively drug-resistant tuberculosis (XDR-TB), a form of the disease against which broader anti-TB drugs are powerless. Now, advances in immunology, chemistry, and biomolecular engineering are helping scientists to gain better insight into the complex cellular processes of Mycobacterium tuberculosis and the disease it causes. This could pave the way for the development of innovative diagnostics, vaccines, and new treatments for these tuberculosis superbugs. This thesis examines why tuberculosis kill millions of people till this day and scientists’ best efforts alone can’t win the war.","abstract_html":"For decades, a dearth of scientific research, inadequate treatment and diagnostic tools have slowed progress in the fight to control tuberculosis globally. Scientists have developed important drugs, such as isoniazid, rifampin, and pyrazinamide, against the disease. But these drugs must be taken for several months, are sometimes ineffective, and can cause debilitating side effects. What’s more, if people don’t finish their treatments, it can lead to multidrug-resistant tuberculosis (MDR-TB), a form of the disease that is resistant to two of the four common drugs against TB, or, even more worryingly, extensively drug-resistant tuberculosis (XDR-TB), a form of the disease against which broader anti-TB drugs are powerless. Now, advances in immunology, chemistry, and biomolecular engineering are helping scientists to gain better insight into the complex cellular processes of Mycobacterium tuberculosis and the disease it causes. This could pave the way for the development of innovative diagnostics, vaccines, and new treatments for these tuberculosis superbugs. This thesis examines why tuberculosis kill millions of people till this day and scientists’ best efforts alone can’t win the war.","abstract_has_math":false,"creators":["Tsann, Abdullahi"],"institution":"Massachusetts Institute of Technology","degree_name":"Master","degree_level":null,"degree_discipline":null,"degree_department":"Massachusetts Institute of Technology. Program in Comparative Media Studies/Writing","school":null,"contributors":[],"advisors":["Greenwood, Veronique"],"committee_chairs":[],"committee_members":[],"year":2023,"date_issued":"2023-09","date_published":"2023-09","updated_at":"2026-07-22T22:22:21Z","subjects":[],"languages":[],"rights":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"],"rights_urls":["https://rightsstatements.org/page/InC-EDU/1.0/"],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1721.1/152712","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Greenwood, Veronique"]},{"key":"dc:contributor.department","label":"Department","values":["Massachusetts Institute of Technology. Program in Comparative Media Studies/Writing","Massachusetts Institute of Technology. Graduate Program in Science Writing"]},{"key":"dc:creator","label":"Author","values":["Tsann, Abdullahi"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2023-11-02T20:10:16Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2023-11-02T20:10:16Z"]},{"key":"dc:date.issued","label":"Date","values":["2023-09"]},{"key":"dc:publisher","label":"Institution","values":["Massachusetts Institute of Technology"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master","Master of Science in Science Writing"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights","label":"Dc Rights","values":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"]},{"key":"dc:rights.uri","label":"Rights URI","values":["https://rightsstatements.org/page/InC-EDU/1.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1721.1/152712"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["For decades, a dearth of scientific research, inadequate treatment and diagnostic tools have slowed progress in the fight to control tuberculosis globally. Scientists have developed important drugs, such as isoniazid, rifampin, and pyrazinamide, against the disease. But these drugs must be taken for several months, are sometimes ineffective, and can cause debilitating side effects. What’s more, if people don’t finish their treatments, it can lead to multidrug-resistant tuberculosis (MDR-TB), a form of the disease that is resistant to two of the four common drugs against TB, or, even more worryingly, extensively drug-resistant tuberculosis (XDR-TB), a form of the disease against which broader anti-TB drugs are powerless. Now, advances in immunology, chemistry, and biomolecular engineering are helping scientists to gain better insight into the complex cellular processes of Mycobacterium tuberculosis and the disease it causes. This could pave the way for the development of innovative diagnostics, vaccines, and new treatments for these tuberculosis superbugs. This thesis examines why tuberculosis kill millions of people till this day and scientists’ best efforts alone can’t win the war."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["S.M."]},{"key":"dc:title","label":"Title","values":["The Consumer of Humans"]}]}],"canonical_facts":{"dc:contributor.advisor":["Greenwood, Veronique"],"dc:contributor.department":["Massachusetts Institute of Technology. Program in Comparative Media Studies/Writing","Massachusetts Institute of Technology. Graduate Program in Science Writing"],"dc:creator":["Tsann, Abdullahi"],"dc:date.accessioned":["2023-11-02T20:10:16Z"],"dc:date.available":["2023-11-02T20:10:16Z"],"dc:date.issued":["2023-09"],"dc:description.abstract":["For decades, a dearth of scientific research, inadequate treatment and diagnostic tools have slowed progress in the fight to control tuberculosis globally. Scientists have developed important drugs, such as isoniazid, rifampin, and pyrazinamide, against the disease. But these drugs must be taken for several months, are sometimes ineffective, and can cause debilitating side effects. What’s more, if people don’t finish their treatments, it can lead to multidrug-resistant tuberculosis (MDR-TB), a form of the disease that is resistant to two of the four common drugs against TB, or, even more worryingly, extensively drug-resistant tuberculosis (XDR-TB), a form of the disease against which broader anti-TB drugs are powerless. Now, advances in immunology, chemistry, and biomolecular engineering are helping scientists to gain better insight into the complex cellular processes of Mycobacterium tuberculosis and the disease it causes. This could pave the way for the development of innovative diagnostics, vaccines, and new treatments for these tuberculosis superbugs. This thesis examines why tuberculosis kill millions of people till this day and scientists’ best efforts alone can’t win the war."],"dc:description.degree":["S.M."],"dc:identifier.uri":["https://hdl.handle.net/1721.1/152712"],"dc:publisher":["Massachusetts Institute of Technology"],"dc:rights":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"],"dc:rights.uri":["https://rightsstatements.org/page/InC-EDU/1.0/"],"dc:title":["The Consumer of Humans"],"dc:type":["Thesis"],"thesis:degree_name":["Master","Master of Science in Science Writing"]},"updated_at":"2026-07-22T22:22:21Z"}